NightstaRx Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

NightstaRx Ltd (NightstaRx) a subsidiary of Nightstar Therapeutics PLC is a clinical-stage gene therapy company that engaged in developing and commercializing novel. The company also involved in providing one-time treatments for patients suffering from rare inherited retinal diseases. It provides NSR-REP1, is developed for the treatment of choroideremia (CHM), degenerative, X-linked genetic retinal disorder. NightstaRx is headquartered in London, England, the UK.

NightstaRx Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
NightstaRx Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NightstaRx Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NightstaRx Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NightstaRx Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NightstaRx Ltd, Medical Devices Deals, 2012 to YTD 2018 9
NightstaRx Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NightstaRx Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
NightstaRx Raises USD45 Million in Series C Financing 11
NightstaRx Raises USD35 Million in Series B Financing Round 12
Nightstar Raises Additional USD8.2 Million in Venture Financing Round 13
NightstaRx Raises US$19.8 Million In Venture Financing 14
Licensing Agreements 15
NightstaRx Enters into Licensing Agreement with Oxford University 15
NightstaRx Expands Licensing Agreement with Isis Innovation 16
NightstaRx Enters into Licensing Agreement with Oxford University Innovation 17
NightstaRx Ltd - Key Competitors 18
NightstaRx Ltd - Key Employees 19
NightstaRx Ltd - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Aug 13, 2018: Nightstar Therapeutics reports second quarter 2018 financial results and business highlights 21
Aug 01, 2017: Nightstar Appoints Tuyen Ong as Chief Development Officer 23
Corporate Communications 24
Jul 13, 2017: Nightstar Appoints David Lubner to its Board of Directors 24
May 02, 2017: NightstaRx Appoints Ophthalmology Industry Veteran Scott Whitcup to Board of Directors 25
Apr 04, 2017: NightstaRx Appoints Healthcare Finance Leader Senthil Sundaram as Chief Financial Officer 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List Of Tables


NightstaRx Ltd, Pharmaceuticals & Healthcare, Key Facts 2
NightstaRx Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NightstaRx Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NightstaRx Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NightstaRx Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
NightstaRx Ltd, Medical Devices Deals, 2012 to YTD 2018 9
NightstaRx Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NightstaRx Raises USD45 Million in Series C Financing 11
NightstaRx Raises USD35 Million in Series B Financing Round 12
Nightstar Raises Additional USD8.2 Million in Venture Financing Round 13
NightstaRx Raises US$19.8 Million In Venture Financing 14
NightstaRx Enters into Licensing Agreement with Oxford University 15
NightstaRx Expands Licensing Agreement with Isis Innovation 16
NightstaRx Enters into Licensing Agreement with Oxford University Innovation 17
NightstaRx Ltd, Key Competitors 18
NightstaRx Ltd, Key Employees 19

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

NightstaRx Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NightstaRx Ltd (NightstaRx) a subsidiary of Nightstar Therapeutics PLC is a clinical-stage gene therapy company that engaged in developing and commercializing novel. The company also involved in providing one-time treatments

USD 250 View Report

Vivergo Fuels Ltd - Strategic SWOT Analysis Review

Vivergo Fuels Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report

Merafe Resources Ltd - Strategy, SWOT and Corporate Finance ReportMerafe Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available